the estimate for CFS for 2010 is $3 million, down from $4m in 2007/2008/2009
and $5m in 2005/2006. Perhaps something that could be brought up in
advocacy. Fibromyalgia is listed as $13m for 2009 and 2010. Tom]
http://report.nih.gov/rcdc/categories/
Home > Estimates of Funding for Various Research, Condition, and Disease
Categories (RCDC)
Estimates of Funding for Various Research, Condition, and Disease Categories
(RCDC)
Table Published January 15, 2009
Table Revised May 7, 2009: Columns for FY 2009 and FY 2010 Estimates updated
This table displays the annual support level for various research,
condition, and disease categories based on grants, contracts, and other
funding mechanisms used across the National Institutes of Health (NIH).
At the request of Congress, the NIH embarked on a process to provide better
consistency and transparency in the reporting of its funded research. This
new process, implemented through the Research, Condition, and Disease
Categorization (RCDC) system, uses sophisticated text data mining
(categorizing and clustering using words and multiword phrases) in
conjunction with NIH-wide definitions used to match projects to categories.
The definitions are a list of terms and concepts selected by NIH scientific
experts to define a research category. Due to significant methodology
changes, it is likely that annual totals for categories (year over year)
will exhibit a noticeable one-time adjustment. The research category levels
represent the NIH's best estimates based on the category definitions.
The NIH does not expressly budget by category. The annual estimates reflect
amounts that change as a result of science, actual research projects funded,
and the NIH budget. The research categories are not mutually exclusive.
Individual research projects can be included in multiple categories so
amounts depicted within each column of this table do not add up to 100
percent of NIH-funded research.
The FY 2005 and FY 2006 data were produced from a reporting process
historically used by NIH. The technical elements of the previous reporting
process did not have the ability to produce uniform results and led to wide
variability in the way research categories were coded. This process caused
inconsistencies in reporting data. RCDC's use of data mining improves the
consistency and eliminates the wide variability in defining the research
categories reported. To illustrate the effect of the RCDC methodology
change, the table shows a side-by-side comparison view of FY 2007 levels
produced with the prior method compared with levels that would have resulted
if the new methodology had been implemented.
Total Number of Research/Disease Areas: 215
Click here for instructions on how to use the data table below.
Research/Disease Areas (Dollars in millions and rounded); FY 2005 Actual; FY
2006 Actual; FY 2007 Actual NIH Historical Method; FY 2007 Actual Revised
Method; NIH FY 2008 Actual FY 2009 Estimated; FY 2010 Estimated
Acute Respiratory Distress Syndrome $72 $74 $48 $87 $82 $84 $85
Agent Orange & Dioxin $20 $17 $18 $15 $13 $14 $14
Aging $2,415 $2,431 $2,462 $1,879 $1,965 $2,019 $2,045
Alcoholism $512 $511 $521 $443 $452 $466 $473
Allergic Rhinitis (Hay Fever) $3 $4 $5 $7 $6 $6 $6
ALS $42 $44 $39 $40 $43 $44 $45
Alzheimer's Disease $656 $643 $645 $411 $412 $423 $428
American Indians / Alaska Natives $140 $155 $141 $159 $142 $147 $149
Anorexia $14 $15 $12 $8 $7 $7 $7
Anthrax $183 $150 $105 $160 $134 $137 $139
Antimicrobial Resistance $217 $221 $269 $209 $228 $234 $237
Aphasia $3 $15 $14 $20 $22 $22 $23
Arctic $22 $17 $19 $25 $22 $23 $23
Arthritis $368 $355 $339 $222 $232 $238 $241
Assistive Technology $138 $182 $184 $192 $215 $221 $224
Asthma $289 $283 $294 $252 $246 $252 $256
Ataxia Telangiectasia $10 $9 $11 $14 $13 $13 $13
Atherosclerosis $322 $337 $347 $468 $460 $472 $477
Attention Deficit Disorder (ADD) $107 $116 $107 $61 $60 $62 $63
Autism $102 $108 $127 $93 $118 $122 $141
Autoimmune Disease $589 $598 $587 $759 $762 $783 $790
Basic Behavioral and Social Science $1,065 $1,062 $1,104 $1,119 $1,149
$1,182 $1,198
Batten Disease $9 $8 $8 $5 $5 $5 $6
Behavioral and Social Science $3,044 $3,001 $3,060 $3,157 $3,215
$3,316 $3,362
Biodefense 1/ $1,696 $1,766 $1,735 $1,735 $1,736 $1,777 $1,793
Bioengineering $1,318 $1,546 $1,469 $2,610 $2,853 $2,932 $2,973
Biotechnology $10,889 $9,974 $9,814 $5,344 $5,179 $5,390 $5,468
Brain Cancer $157 $178 $193 $204 $194 $200 $205
Brain Disorders $4,784 $4,732 $4,670 $3,592 $3,729 $3,835 $3,888
Breast Cancer $700 $718 $707 $729 $726 $748 $769
Burden of Illness $433 $508 $524 $60 $48 $49 $50
Cancer $5,639 $5,575 $5,643 $5,549 $5,570 $5,748 $6,016
Cardiovascular $2,333 $2,349 $2,370 $1,942 $2,027 $2,081 $2,103
Cerebral Palsy $23 $18 $16 $30 $28 $29 $29
Cervical Cancer $96 $97 $96 $67 $69 $71 $73
Charcot-Marie-Tooth Disease - $7 $7 $9 $12 $13 $13
Child Abuse and Neglect Research $40 $38 $38 $41 $30 $31 $32
Childhood Leukemia $60 $53 $55 $50 $39 $40 $41
Chronic Fatigue Syndrome $5 $5 $4 $4 $4 $4 $3
Chronic Liver Disease and Cirrhosis $410 $408 $379 $253 $241 $248
$251
Chronic Obstructive Pulmonary Disease $63 $67 $91 $72 $75 $78 $79
Climate Change $57 $50 $47 $4 $4 $4 $4
Clinical Research $8,719 $8,785 $9,116 $9,862 $9,629 $9,931 $10,086
Clinical Trials $2,863 $2,767 $2,949 $3,422 $3,562 $3,663 $3,719
Colo-Rectal Cancer $284 $269 $282 $273 $274 $282 $290
Complementary and Alternative Medicine $306 $301 $299 $426 $430 $443
$450
Conditions affecting unborn children $108 $103 $110 $81 $81 $83 $84
Contraception/Reproduction $340 $335 $314 $460 $473 $486 $492
Cooley's Anemia $42 $42 $34 $22 $22 $22 $22
Cost Effectiveness Research $134 $143 $155 $50 $49 $50 $51
Crohn's Disease $59 $64 $69 $47 $51 $52 $52
Cystic Fibrosis $89 $85 $82 $78 $90 $93 $94
Dental/Oral and Craniofacial Disease $415 $413 $417 $484 $463 $476
$483
Depression $329 $335 $345 $398 $402 $412 $418
Diabetes 2/ $1,055 $1,038 $1,037 $1,069 $1,080 $1,104 $1,110
Diagnostic Radiology $788 $712 $694 $1,046 $1,095 $1,125 $1,142
Diethylstilbestrol (DES) $9 $8 $6 $5 $4 $4 $4
Digestive Diseases $1,237 $1,252 $1,234 $1,460 $1,426 $1,466 $1,487
Digestive Diseases - (Gallbladder) $7 $7 $6 $6 $7 $7 $7
Digestive Diseases - (Peptic Ulcer) $18 $17 $23 $15 $14 $14 $14
Down Syndrome $15 $14 $16 $16 $17 $17 $18
Drug Abuse (NIDA Only) 3/ $1,006 $990 $1,001 $1,001 $1,007 $1,033
$1,045
Duchenne/ Becker Muscular Dystrophy $17 $18 $23 $23 $22 $23 $23
Dystonia $19 $19 $16 $18 $15 $16 $16
Emerging Infectious Diseases $1,872 $1,857 $1,816 $1,733 $2,098 $2,156
$2,179
Emphysema $21 $17 $21 $30 $29 $29 $30
Endometriosis $10 $12 $12 $12 $15 $15 $16
Epilepsy $105 $103 $105 $145 $145 $150 $152
Estrogen $183 $153 $164 $283 $245 $252 $256
Eye Disease And Disorders Of Vision $715 $705 $714 $800 $796 $818
$827
Facioscapulohumeral Muscular Dystrophy $2 $2 $4 $3 $3 $3 $3
Fetal Alcohol Syndrome $28 $29 $34 $32 $34 $35 $35
Fibroid Tumors (Uterine) $15 $15 $14 $20 $16 $17 $17
Fibromyalgia $10 $9 $9 $11 $12 $13 $13
Food Safety $329 $316 $278 $230 $244 $250 $253
Fragile X Syndrome $22 $20 $27 $22 $26 $27 $28
Frontotemporal Dementia (FTD) $29 $33 $31 $17 $17 $18 $18
Gene Therapy $355 $356 $325 $250 $249 $255 $259
Gene Therapy Clinical Trials $31 $32 $31 $12 $16 $16 $17
Genetic Testing $422 $417 $395 $402 $383 $395 $402
Genetics $4,840 $4,878 $4,878 $7,000 $6,872 $7,066 $7,173
Global Warming Climate Change $24 $58 $56 $1 $1 $1 $1
Health Disparities 4/ $2,699 $2,766 $2,744 $2,744 $2,614 $2,691
$2,725
Health Effects of Climate Change $159 $157 $164 $258 $286 $295 $300
Health Services $940 $929 $1,023 $730 $743 $779 $792
Heart Disease $2,087 $2,087 $2,126 $1,126 $1,217 $1,249 $1,263
Heart Disease - Coronary Heart Disease $397 $398 $382 $379 $367 $377
$381
Hematology $1,122 $1,114 $1,128 $881 $894 $919 $935
Hepatitis $179 $177 $174 $176 $180 $185 $187
Hepatitis - A $5 $3 $2 $6 $6 $6 $6
Hepatitis - B $39 $36 $42 $53 $53 $54 $55
Hepatitis - C $121 $122 $108 $100 $93 $95 $96
HIV/AIDS 5/ $2,921 $2,902 $2,906 $2,906 $2,928 $3,010 $3,055
Hodgkin's Disease $18 $21 $17 $12 $16 $17 $17
Homelessness $24 $21 $18 $14 $13 $13 $13
Homicide and Legal Interventions $12 $11 $8 $1 * - -
HPV and/or Cervical Cancer Vaccines $16 $14 $20 $16 $19 $19 $20
Human Fetal Tissue 6/ $24 $23 $19 ** $40 $41 $42
Human Genome $1,084 $1,065 $1,099 $1,246 $1,259 $1,297 $1,317
Huntington's Disease $48 $48 $53 $49 $51 $53 $53
Hyperbaric Oxygen $2 $2 $2 $3 $4 $4 $4
Hypertension $371 $395 $390 $231 $263 $270 $273
Immunization $1,438 $1,438 $1,342 $1,713 $1,734 $1,779 $1,804
Infant Mortality/ (LBW) $504 $478 $464 $227 $246 $253 $256
Infectious Diseases $3,188 $3,132 $3,059 $3,433 $3,575 $3,678 $3,725
Infertility $40 $40 $51 $65 $73 $75 $76
Inflammatory Bowel Disease $70 $72 $80 $74 $81 $83 $83
Influenza $164 $207 $271 $280 $204 $209 $212
Injury - Childhood Injuries $26 $28 $27 $28 $26 $27 $27
Injury - Trauma - (Head and Spine) $241 $233 $219 $164 $150 $155 $157
Injury - Traumatic brain injury $87 $85 $82 $73 $59 $61 $62
Injury - Unintentional Childhood Injury $22 $25 $21 $17 $15 $16 $16
Injury (total) Accidents/Adverse Effects $353 $355 $403 $299 $299 $308
$312
Interstitial Cystitis $26 $25 $23 $10 $10 $10 $10
Kidney Disease $427 $434 $450 $531 $523 $536 $540
Lead Poisoning $15 $15 $15 $13 $9 $9 $9
Liver Cancer $82 $88 $90 $103 $89 $91 $93
Liver Disease $454 $450 $423 $589 $562 $577 $584
Lung $1,025 $978 $1,013 $1,169 $1,211 $1,244 $1,262
Lung Cancer $289 $266 $249 $164 $169 $175 $179
Lupus $89 $97 $84 $113 $126 $129 $130
Lyme Disease $27 $24 $22 $26 $22 $22 $23
Lymphoma $177 $170 $158 $186 $193 $199 $204
Macular Degeneration $58 $60 $70 $135 $135 $138 $140
Malaria $104 $98 $104 $112 $132 $136 $141
Malaria Vaccine $44 $35 $36 $31 $32 $33 $33
Mental Health $1,848 $1,824 $1,853 $2,061 $2,086 $2,142 $2,173
Mental Retardation (Intellectual and Developmental Disabilities (IDD)) $192
$188 $204 $305 $350 $360 $365
Methamphetamine $43 $45 $45 $66 $67 $69 $70
Mind and Body $152 $136 $133 $571 $567 $583 $591
Minority Health 4/ $2,404 $2,423 $2,407 $2,407 $2,396 $2,474 $2,508
Mucopolysaccharidoses (MPS) $10 $10 $10 $8 $7 $7 $7
Multiple Sclerosis $110 $110 $98 $149 $169 $173 $176
Muscular Dystrophy $40 $40 $47 $58 $56 $58 $59
Myasthenia Gravis $5 $9 $6 $10 $9 $10 $10
Myotonic Dystrophy $6 $7 $8 $9 $9 $9 $9
Nanotechnology $165 $192 $215 $257 $304 $311 $326
Networking and Information Technology R&D $509 $423 $507 $959 $911
$936 $950
Neurodegenerative $1,215 $1,217 $1,166 $1,579 $1,621 $1,668 $1,690
Neurofibromatosis $17 $16 $13 $12 $14 $15 $15
Neuropathy $51 $54 $59 $118 $121 $124 $126
Neurosciences $4,902 $4,830 $4,809 $5,102 $5,224 $5,372 $5,444
Nutrition $1,072 $1,039 $1,075 $1,327 $1,391 $1,429 $1,444
Obesity $519 $594 $661 $595 $664 $681 $687
Organ Transplantation $358 $363 $358 $187 $175 $180 $181
Orphan Drug $1,228 $1,255 $1,158 $653 $645 $664 $678
Osteogenesis Imperfecta $9 $5 $5 $8 $5 $5 $5
Osteoporosis $191 $169 $164 $167 $183 $188 $190
Otitis Media $15 $17 $15 $20 $18 $19 $19
Ovarian Cancer $106 $102 $103 $89 $96 $99 $102
Paget's Disease $6 $6 $4 $1 $1 $1 $1
Pain Conditions - Chronic $229 $220 $224 $277 $279 $287 $291
Parkinson's Disease $225 $208 $187 $143 $152 $156 $158
Pediatric 9/ $3,210 $3,161 $3,173 $2,622 $2,771 $2,864 $2,906
Pediatric AIDS 7/ $279 $276 $262 $262 $241 $255 $260
Pediatric Research Initiative 10/ $145 $141 $171 ** $209 $212 $215
Pelvic Inflammatory Disease $4 $4 $3 $4 $3 $3 $3
Perinatal - Birth - Preterm (LBW) $394 $374 $351 $181 $197 $203 $206
Perinatal - Neonatal Respiratory Distress Syndrome $10 $8 $9 $23 $18
$19 $19
Perinatal Period - Conditions Originating in Perinatal Period $429 $407
$387 $413 $449 $461 $467
Pick's Disease $1 $1 $1 $3 $2 $3 $3
Pneumonia $154 $145 $132 $105 $93 $95 $96
Pneumonia & Influenza $317 $351 $405 $382 $295 $303 $307
Polycystic Kidney Disease $25 $32 $36 $33 $41 $42 $42
Prevention $7,100 $6,815 $6,729 $4,596 $4,623 $4,752 $4,822
Prostate Cancer $373 $348 $345 $295 $290 $299 $307
Psoriasis $6 $8 $10 $22 $8 $8 $8
Regenerative Medicine $591 $614 $575 $697 $723 $743 $753
Rehabilitation $325 $324 $344 $379 $403 $415 $421
Rett Syndrome $6 $5 $6 $6 $9 $10 $10
Reye's Syndrome $1 $1 $1 $0 $0 - -
Rural Health $199 $202 $208 $173 $170 $175 $178
Schizophrenia $353 $364 $358 $220 $249 $256 $259
Scleroderma $11 $11 $12 $12 $20 $21 $21
Septicemia $42 $49 $49 $93 $95 $98 $99
Sexually Transmitted Diseases/Herpes $252 $264 $288 $282 $245 $251
$255
Sickle Cell Disease $91 $91 $94 $78 $80 $83 $83
Sleep Research $189 $199 $190 $219 $225 $232 $235
Small Pox $187 $149 $122 $142 $94 $97 $98
Smoking and Health $533 $517 $534 $324 $310 $319 $325
Spina Bifida $10 $11 $9 $14 $15 $16 $16
Spinal Cord Injury $89 $66 $64 $90 $80 $82 $84
Spinal Muscular Atrophy $15 $15 $11 $11 $10 $10 $10
Stem Cell Research $609 $643 $657 $968 $938 $963 $977
Stem Cell Research - Embryonic - Human $40 $38 $42 $74 $88 $91 $92
Stem Cell Research - Embryonic - Non-Human $97 $110 $106 $120 $150
$154 $155
Stem Cell Research - Nonembryonic - Human $199 $206 $203 $226 $297
$305 $311
Stem Cell Research - Nonembryonic - Non-Human $273 $289 $306 $400 $497
$511 $518
Stem Cell Research - Umbilical Cord Blood/ Placenta $18 $19 $22 $44 $46
$47 $48
Stem Cell Research - Umbilical Cord Blood/ Placenta - Human $15 $16 $19
$38 $38 $39 $39
Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human $3 $4 $2
$9 $9 $9 $9
Stroke $342 $342 $340 $288 $296 $305 $310
Substance Abuse 8/ $1,508 $1,490 $1,523 $1,636 $1,763 $1,811 $1,836
Sudden Infant Death Syndrome $84 $77 $81 $25 $29 $30 $30
Suicide $34 $32 $43 $52 $39 $40 $41
Teenage Pregnancy $26 $21 $16 $24 $21 $21 $22
Temporomandibular Muscle/Joint Disorder (TMJD) $20 $17 $15 $18 $19 $20
$20
Tobacco $531 $515 $536 $325 $311 $320 $326
Topical Microbicides $66 $88 $99 $92 $102 $104 $105
Tourette Syndrome $13 $13 $11 $9 $8 $9 $9
Transmissible Spongiform Encephalopathy (TSE) $37 $35 $43 $50 $44 $45
$45
Transplantation $545 $551 $534 $544 $519 $533 $540
Tuberculosis $158 $150 $166 $188 $142 $145 $147
Tuberculosis Vaccine $26 $22 $17 $23 $18 $19 $19
Tuberous Sclerosis $9 $9 $12 $20 $20 $21 $21
Urologic Diseases $576 $536 $526 $535 $534 $550 $562
Uterine Cancer $39 $28 $22 $24 $16 $16 $17
Vaccine Related $1,450 $1,449 $1,358 $1,659 $1,632 $1,675 $1,698
Vaccine related (AIDS) 7/ $511 $566 $597 $597 $556 $557 $557
Vector-Borne Diseases $447 $464 $424 $478 $417 $428 $433
Violence Against Women $22 $20 $24 $49 $45 $46 $47
Violence Research $121 $113 $106 $190 $183 $188 $191
West Nile Virus $43 $85 $69 $81 $39 $40 $41
Women's Health 4/ $3,551 $3,498 $3,470 $3,470 $3,514 $3,627 $3,683
Youth Violence $69 $67 $60 $123 $115 $119 $120
[-] Data is not available at this time. FY 2009 and FY 2010 estimates will
be displayed upon transmittal of the President's budget request or as
otherwise directed by the U.S. Office of Management & Budget (OMB).
[*] The minimum reporting threshold for a specific disease/condition is
$500,000. Reporting of $0 does not indicate that no research is being
conducted.
[**] No methodology was identified for RCDC in 2007; therefore there is no
data available under the "FY 2007 NIH Revised Method" column.
1/ Reporting for this category does not follow the standard RCDC process.
The total amount reported is consistent with reporting requirements for this
category to the U.S. Office of Management & Budget (OMB). The project
listing does not include non-project or other support costs associated with
the annual total for this category. Additional information on this category
is available at
http://www3.niaid.nih.gov/topics/BiodefenseRelated/default.htm.
2/ Includes research funded from the Type 1 diabetes appropriation.
3/ Reporting for this category does not follow the standard RCDC process.
Spending is reported consistent with U.S. Office of National Drug Control
Policy (ONDCP) requirements (Only NIDA). More information on this area is
available at http://www.nida.nih.gov/drugpages.html.
4/ Reporting for this category does not follow the standard RCDC process.
This category assigns project funding according to populations tracked by
gender or ethnicity. The databases used to track gender/ethnicity are
complex and not currently compatible with the RCDC system.
5/ Reporting for this category does not follow the standard RCDC process.
These are project listings only and non-project or other support costs
associated with the annual total for the category are not included. More
information on this area is available at http://www.oar.nih.gov/.
6/ Reporting for this category does not follow the standard RCDC process.
This category uses a non-standard approach involving subject matter expert
reviews of manually collected project listings.
7/ Reporting for this category does not follow the standard RCDC process.
These are project listings only and non-project or other support costs
associated with the annual total for the category are not included. More
information on the budget associated with the category is available at
http://www.oar.nih.gov/. Research reported for this category is also
captured under the broader HIV/AIDS category.
8/ Reporting for this category does not follow the standard RCDC process.
This category includes all spending reported under the Drug Abuse category
as well as projects categorized under the broader area of Substance Abuse.
These are project listings only. More information on this area is available
at http://www.nida.nih.gov/drugpages.html.
9/ The reported total displayed in the "FY 2007 Actual-Historical Method"
column does not include $69 million associated with the National Children's
Study later identified to this category during development of subsequent
reports. The recast FY 2007 total for this category that fully accounts for
spending under the historical method is approximately $3,242 million.
10/ The reported total displayed in the "FY 2007 Actual-Historical Method"
column does not include $25.8 million later identified to this category
during development of subsequent reports. The recast FY 2007 total for this
category that fully accounts for spending under the historical method is
approximately $197 million.
---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
Select list topic options at http://www.co-cure.org/topics.htm
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------
